FALANGA ANNA

Ruolo: 
Professore straordinario a tempo determinato
Settore scientifico disciplinare: 
MALATTIE DEL SANGUE (MED/15)

Pubblicazioni

  • Key, N., Khorana, A., Kuderer, N., Bohlke, K., Lee, A., Arcelus, J., et al. (2020). Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. JOURNAL OF CLINICAL ONCOLOGY, 38(5), 496-520. Dettaglio
  • Leader, A., Ten Cate, V., Ten Cate-Hoek, A., Beckers, E., Spectre, G., Giaccherini, C., et al. (2020). Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 77, 86-96. Dettaglio
  • Poli, D., Antonucci, E., Vignini, E., Martinese, L., Testa, S., Simioni, P., et al. (2020). Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs. EUROPEAN JOURNAL OF INTERNAL MEDICINE. Dettaglio
  • Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., et al. (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID-19. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 18(5), 1023-1026. Dettaglio
  • Thachil, J., Tang, N., Gando, S., Falanga, A., Levi, M., Clark, C., et al. (2020). Type and dose of heparin in Covid-19: Reply. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Dettaglio